The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to pandemic policy interventions, including the timing of vaccine boosters.

Matéria original


Bat coronaviruses related to SARS-CoV-2 and infectious for human cells


Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19